TECNIS Odyssey US Roll-Out

Johnson & Johnson (J&J) is expanding the roll-out of its TECNIS Odyssey presbyopia-correcting intraocular lens (PC-IOL) in the US.

The TECNIS Odyssey IOL is built on the TECNIS platform, “providing two-times better contrast in low lighting than PanOptix,” J&J reports (1,2). The company adds that TECNIS Odyssey IOL patients “are able to read 14 percent smaller print on average than PanOptix IOL patients (3) and 93 percent reported no or mild halos, glare, or starbursts one month after surgery” (4).

“TECNIS Odyssey patients have reported outstanding visual outcomes following surgery,” said Peter Menziuso, Company Group Chairman, Vision, Johnson & Johnson, “which is why we are excited [to be] expanding the roll-out across the US.”

George Waring IV, Medical Director of the Waring Vision Institute in Mt. Pleasant, SC and a consultant of Johnson & Johnson Vision, observed that the TECNIS Odyssey “falls under the ISO standard of full vision range and allows for the benefits of not only a full range of vision but also extraordinary contrast both day and night.” He noted that he is “also seeing a high tolerance to refractive, minimal dysphotopsias, and very high satisfaction in my patients.”

Douglas Grayson, Medical Director and Chief Cataract & Glaucoma Surgeon at Omni Eye Services, West Orange, NJ, told The Ophthalmologist that his patients “are able to see distance and near, and night vision has improved.” He says, “TECNIS Odyssey is a major advancement in design, providing a full range of vision without compromise, in comparison to other J&J IOLs, as well as competitive IOLs.”

Meanwhile, Liz Yeu – current President of the American Society of Cataract and Refractive Surgery (ASCRS), partner at Virginia Eye Consultants, and Assistant Professor of Ophthalmology at the Eastern Virginia Medical School, Norfolk, VA – adds, “I’ve had the opportunity to implant numerous patients and can confidently say that the quality and seamless range of vision this IOL brings have been well received. Best of all, the night vision symptoms are quite low, and these nuanced advances are such appreciated attributes for patients who are receiving quality without compromise.”

As part of the roll-out, J&J is launching TECNIS Odyssey IOL Peer Connect, an initiative designed to foster “direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.” Eye care professionals can access the interactive platform here.